Research funder · United States
American Cancer Society
Health organization seeking to cure and treat cancer
- Grants since 2016
- 2 163
- Awarded, last 5 years (where amounts are published)
- 648.5M
- Funded works, last 5 years
- 5 405
- Funded works, all time
- 33.1k
Grants
2026–2029 · award
Molecular mechanisms of transuridyltransferase activity and substrate specificity
Natalie Jones · Cold Spring Harbor Laboratory
2026–2028 · award
Selective targeting of genome amplifications by CRISPR-Cas9 nickases to promote cancer cell death
Scot Wolfe · University of Massachusetts Chan Medical School
2026–2028 · award
Ablating Myc-Driven Cancer Using Programmable RNA Sensors
Xiaojing Gao · The Board Of Trustees Of The Leland Stanford Junior University
2026–2028 · award
Markey STRONG Post-baccalaureate Program
Kathleen O'Connor · University Of Kentucky Research Foundation
2026–2029 · award
Genomic instability after telomere crisis shapes viral integration and Merkel cell carcinoma evolution
Jiawen Yang · Dana-Farber Cancer Institute
2026–2028 · award
A Lysosomally-Targeted Antibody-Drug Conjugate for the Treatment of Renal Cell Carcinoma
Carolyn Bertozzi
2026–2028 · award
Targeting VCP-Dependent Stabilization of Mutant p53 in Pancreatic Cancer
Hua Lu · Tulane University
2026–2029 · award
YTHDF2 Controls T9 Cell Identity and Its Targeting Enhances EGFR-CAR Activity in Glioblastoma
Fujing Ge · University of California, Irvine
2026–2029 · award
Uncovering the molecular mechanisms of LRRK2 regulation in the inflammatory response
Katherine Surridge · Weill Cornell Medicine
2026–2030 · award
Synergistic Utility of MRF and FET-PET in Recurrent Glioblastomas: Mapping Fractional Tumor Burden and Predicting Therapeutic Response
Chaitra Badve · University Hospitals Cleveland Medical Center
2026–2030 · award
Elucidating the role of PRMT5 in Cutaneous T-cell Lymphoma
Walter Hanel · The Ohio State University
2026–2028 · award
Leveraging a unique patient-derived immune humanized mouse platform to enhance CAR T cell therapy for pediatric osteosarcoma
Lindsay Talbot · St. Jude Children's Research Hospital
2026–2028 · award
Regulation of dendritic cell phenotype and functions in melanoma
Kevin Barry · Fred Hutch Cancer Center
2026–2030 · award
Mechanisms of the replication stress response
Daniel Semlow · California Institute of Technology
2026–2029 · award
Signal transduction from the cell surface to the nucleus in Hedgehog pathway-dependent cancers
Guibing Liu · University of Utah
2026–2029 · award
Therapeutic targeting of ZBP1 in cardiomyocytes to mitigate chemotherapy-induced cardiac dysfunction
Arunachalam Sekar · Jackson Laboratory
2026–2029 · award
Assessing the functional relevance of ovarian cancer-identified RAD51D variants of unknown significance
Noah J Goff · University of Pennsylvania
2026–2028 · award
Enhancing Prostate Cancer Trials in North Philadelphia at Jefferson Einstein Medical Center, Community Site of Sidney Kimmel Comprehensive Cancer Ctr
Edouard Trabulsi · Einstein Healthcare Network
2026–2030 · award
Biological Consequences of Neural Signatures in Fusion-Positive Rhabdomyosarcoma
Genevieve Kendall · Abigail Wexner Research Institute
2026–2028 · award
Deciphering histone demethylation in mutant p53-driven cancer initiation
Trinh Phan · The University of Texas Health Science Center at Houston
2026–2028 · award
Engineered Protein Circuits for Cancer Therapy
Michael Elowitz · Howard Hughes Medical Institute
2026–2028 · award
Investigating mechanisms of trastuzumab resistance in pan-cancer PDXs
Funda Meric-Bernstam · The University of Texas MD Anderson Cancer Center
2026–2029 · award
Move with Us: A Multilevel, Faith-based Intervention to Promote Rural Physical Activity and Cancer Prevention
Kelsey Day · University of Virginia
2026–2027 · award
Development of a Novel Ultrasensitive CSF Liquid Biopsy Assay for Clinical Decision Making in High-Grade Glioma
Alexandra Miller · New York University
2026–2028 · award
Targeting the BCL-2 Family to Reprogram T Cells and Enhance CAR T Therapy Efficacy
Nada Aboelella · University of Chicago
2026–2027 · award
Development of Strategies to Study Medical Debt Relief: A Feasibility Study
Betsy Cliff · University of Chicago
2026–2028 · award
Novel immunotherapy targeting KRAS mutants
Possu Huang · The Board Of Trustees Of The Leland Stanford Junior University
2026–2028 · award
SMAhRTs as Targeted Anti-Triple Negative Breast Cancer Therapeutics
Siva Kolluri · Oregon State University
2026–2028 · award
Manufacturing an Immunotherapy-Resistant Hematopoiesis to Treat Acute Myeloid Leukemia
Pietro Genovese · Boston Children's Hospital
2026–2027 · award
Role of Chromatin Remodeling Complexes in Clonal Evolution of Blood Cancers
Darko Barisic · Cornell University
2026–2028 · award
Cardiovascular Consequences of Targeting Estrogen Receptor Signaling in Breast Cancer
Aarti Asnani · Beth Israel Deaconess Medical Center
2026–2029 · award
The Role of GABA in PDAC immunosuppression
Ariana Aquino · Henry Ford Health
2026–2030 · award
Institutional Research Grant
David Cortez · Vanderbilt University
2026–2027 · award
Understanding Lac-Phe, an exercise-induced metabolite, in cancer treatment
Xia Gao · Baylor College of Medicine
2026–2028 · award
Decoding epigenetic and transcriptional programs of immune cells in colorectal cancer using multi-omic and spatial analysis
Sneha Mitra · Memorial Sloan Kettering Cancer Center
2026–2030 · award
Cancer Health Engagement and Action Research (CHEAR) Center
Monica Baskin · Virginia Commonwealth University
2026–2028 · award
Potentiating antibody-drug conjugate activity by controlled co-engagement with internalizing receptor
Xin Zhou · Dana-Farber Cancer Institute
2026–2027 · award
Clone-specific expression as a determinant of disease growth and treatment response in vivo
Ignaty Leshchiner · Trustees Of Boston University
2026–2030 · award
Identifying and characterizing RNA modifications in relapsed or refractory multiple myeloma
Jessica Silva-Fisher · Washington University in St. Louis
2026–2029 · award
Defining the DNA Repair Independent Mitotic Role of 53BP1
Chiara Masnovo · Dana-Farber Cancer Institute